shareholders will have to vote and agree to except the Indicative offer.
The implementation of the Scheme is subject to conditions customary for a transaction of this
nature, including:
• Link Group shareholder approval;
• Approval by the Court;
• Various regulatory approvals;
• The Independent Expert concluding (and continuing to conclude) that the Scheme is fair
and reasonable and in the best interests of Link Group shareholders;
• No Link Group material adverse change; and
• No prescribed occurrences.
The Scheme is not subject to a financing condition
I will vote to not, except the offer.
2021 AGM the remuneration report got a 63.33 % against the report.
This means if they get another strike against the whole board will have to sit for re-election.
This sale, on and off again has been going on for years.
But never seems to get there.
I've lost faith in the chairman and CEO.
Reporting is misleading but the big move a decade ago to take over an English company has not worked and cost the rest of company dearly.
Bad fundamentals result in bad NPAT of $70.747 m
THE BOARD NEEDS TO BE REINVIGORATED.
- Forums
- ASX - By Stock
- LNK
- Rewrite.by Morningstar to 10.dollars
Rewrite.by Morningstar to 10.dollars, page-8
Featured News
Add LNK (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online